Vitamin B12 absorption: intrinsic factor and the 1 % rule
Futures Nutrition Editorial Team · 12 August 2026
Vitamin B12 absorption: intrinsic factor and the 1 % rule
12 August 2026
The short answer: vitamin B12 has two ways into the body, and the good one is the smaller one. The active route via intrinsic factor works reliably, but it is exhausted after roughly 1.5 µg per meal – any more simply does not fit through. Everything above that only seeps passively through the intestinal wall, and it does so on the order of one percent of the amount.
That single number explains almost everything that looks odd on a B12 pack: why a tablet contains 1,000 µg although the reference value is 4 µg. Why two small portions together deliver more than one large one. And why people with a damaged stomach can still swallow tablets instead of receiving injections.
The path of a B12 dose through the body
Vitamin B12 is not simply absorbed, it is handed along. Four stations lie between the mouthful and the bloodstream:
- In the mouth and stomach, gastric acid releases the vitamin from the dietary protein it is bound to. It does not stay free for long: it immediately binds to haptocorrin, a transport protein from saliva that carries it through the acidic environment.
- In the duodenum, enzymes from the pancreas break down the haptocorrin. Only then is the vitamin released again.
- Now intrinsic factor comes into play – a protein produced by the parietal cells of the gastric mucosa. The German Nutrition Society (DGE) sums this step up in one sentence: binding to an intrinsic factor formed in the cells of the stomach is necessary for vitamin B12 from food to be taken up into the intestinal cells.
- In the last section of the small intestine, the ileum, sits a receptor called cubam that recognises exactly this complex and pulls it into the cell.
Four stations means four places where something can jam. A vitamin that is not released from protein in the stomach never even reaches intrinsic factor. And intrinsic factor without a working receptor in the ileum is of no use.
The ceiling applies per meal, not per day
The decisive point about the active route: the number of receptors in the ileum is limited. How clearly so was shown by a study in healthy adults in which crystalline cyanocobalamin was given in three strengths and the absorbed amount was measured.
| Dose given | Share absorbed | Absorbed in absolute terms |
|---|---|---|
| 2.5 µg | about 51 % | 1.16 µg |
| 5 µg | about 27 % | 1.22 µg |
| 10 µg | about 15 % | 1.39 µg |
The middle column falls steeply, the right-hand one barely moves. That is saturation, visible in numbers: whether 2.5 or 10 µg are swallowed, about one microgram arrives via the active route. The authors put the breakpoint at around 2.6 µg per dose; below it roughly 43 % is absorbed, above it hardly any more in absolute terms.
For everyday eating this yields an unremarkable but practical rule: spread out beats bundled. Two meals with 2 µg each together deliver more absorbed B12 than one with 4 µg, because the receptor route frees up in between. That is precisely why the European Food Safety Authority (EFSA) assumes an absorption of around 40 % of the amount supplied for a normal mixed diet – an average across the day, not across one large portion.
The second route: passive diffusion
Alongside the receptor route there is a second, far plainer one: part of the vitamin simply migrates through the intestinal mucosa, without intrinsic factor, without a receptor, without saturation. This route is inefficient but unlimited. In the same study it could be quantified at around one percent of the dose given.
One percent sounds like nothing. With small amounts it is – 5 µg become 0.05 µg. With large amounts the ratio tips: 1,000 µg become around 10 µg, and that passive share alone exceeds what an adult loses per day. EFSA estimates daily losses at 2 to 6 µg.
That is the whole logic behind the number on the tin. 1,000 µg is not 250 times the effect of 4 µg, it is a calculation involving one percent. Anyone who reads the 40,000 % on the back as an overdose is reading a percentage that refers to a labelling reference value – not to an absorbed amount.
Our tablet contains 1,000 µg as methylcobalamin, intended as one intake per day: Vitamin B12 1000 µg, 180 tablets. For the passive route the chemical form is irrelevant – it does not distinguish between the four approved cobalamins.
Why a tablet is absorbed differently from a steak
Here lies a difference that regularly gets lost in shop-floor advice: food B12 and tablet B12 do not start at the same point.
The vitamin in meat, eggs and cheese is bound to protein. Before anything else can happen, gastric acid has to break that bond. The B12 in a tablet, by contrast, is already present in crystalline, free form – this first step is skipped.
The consequence shows up when gastric acid production declines. Someone with atrophic gastritis absorbs protein-bound B12 from foods less well, while crystalline B12 is absorbed to the same extent as in healthy people. In the United States the recommendation is therefore that people over 50 should obtain their B12 mainly from fortified foods or supplements – not because requirements rise, but because the form decides whether gastric acid is needed at all.
Incidentally, this is also why a good blood value after plenty of meat can be deceptive: the amount on the plate says nothing about how much of it was released from the protein.
Who absorbs B12 less well
The DGE names four groups of conditions in which absorption can be impaired regardless of intake: atrophic gastritis, chronic inflammatory bowel diseases (ulcerative colitis, Crohn's disease), exocrine pancreatic insufficiency and the removal of parts of the stomach or intestine. Each of them hits a different one of the four stations.
| What is affected | Which station fails |
|---|---|
| Atrophic gastritis | Gastric acid and intrinsic factor – the vitamin is not released from dietary protein |
| Pernicious anaemia | Intrinsic factor is missing because the immune system turns against the parietal cells |
| Gastric reduction, gastric removal | Intrinsic factor is no longer produced in sufficient quantity |
| Crohn's disease, removal of the ileum | The cubam receptor at the end of the small intestine is missing |
| Exocrine pancreatic insufficiency | The enzymes that break down haptocorrin are missing |
How common this is depends on age: for atrophic gastritis, frequencies of between 7 and 32 % are reported in older adults – a wide range, partly because measurement criteria differ in strictness.
Two groups of medicines come on top of that. Acid blockers act at the same point as atrophic gastritis: less gastric acid, less B12 released from food. And metformin disrupts the last step: what is discussed here is interference with the calcium-dependent binding of the intrinsic-factor-B12 complex to the cubam receptor in the ileum. In 2022 the British medicines regulator MHRA classified lowered B12 levels as a common side effect of metformin and recommends monitoring in patients at risk; the Drug Commission of the German Medical Association passed this information on in the same year. Whether and how monitoring happens is decided by the treating practice – not by the shelf.
Stores and recycling: why it takes years
A healthy adult carries around 2 to 3 mg of vitamin B12, roughly 60 % of it in the liver. Measured against a daily loss of a few micrograms, that is a very large reserve – the DGE accordingly states that where intake was previously adequate, signs of deficiency usually appear only after years of insufficient supply.
This is reinforced by a cycle: the body releases about 1.4 µg of B12 into the small intestine via bile each day, and it reclaims roughly half of that. The catch is that this reclaiming uses the same route – intrinsic factor, cubam receptor, ileum. With impaired absorption, it is therefore not only intake that fails but recycling too. That explains why a deficiency builds up within a few years when absorption is disturbed, while on a purely plant-based diet with an intact gut it can take considerably longer to appear.
What this means in practice
- Splitting helps, as long as you stay in the range of food amounts. With a high-dose tablet it no longer matters: there, almost only the passive route carries the load.
- Sublingual offers no documented advantage. A systematic review covering 16 studies and more than 6,000 participants found no statistically meaningful differences in cobalamin and homocysteine values between oral, sublingual and intramuscular administration. Lozenges are convenient, nothing more.
- Algae products are not a source. The DGE points out that vitamin B12 analogues, for instance in algae or sauerkraut, do not contribute to supply and can further worsen it by blocking the body's transport systems. In other words, they occupy exactly the routes this article is about.
- B12 does not work alone. Folate is also involved in the breakdown of homocysteine to methionine; that is why folic acid products and B12 almost always appear side by side in advice.
All strengths and forms in the range are listed in the vitamin B12 category.
Among the claims authorised for vitamin B12 are these: Vitamin B12 contributes to normal energy-yielding metabolism. Vitamin B12 contributes to normal functioning of the nervous system. Vitamin B12 contributes to normal red blood cell formation. Vitamin B12 contributes to the reduction of tiredness and fatigue. (Regulation (EU) No 432/2012). Food supplements are not a substitute for a balanced and varied diet and a healthy lifestyle.
Frequently asked questions
How much of a 1,000 µg tablet actually arrives? About one microgram via the active route – saturation does not allow more. On top of that comes the passive share of roughly one percent of the dose, so around 10 µg. Together that is well above the daily loss of 2 to 6 µg that EFSA assumes. The remaining 99 % or so is excreted; that is planned for, not a fault of the tablet.
Is it better to take B12 on an empty stomach? For a high-dose tablet it makes hardly any difference, because the passive route needs neither gastric acid nor intrinsic factor. For B12 from foods the opposite applies: there, gastric acid is needed to release the vitamin from the protein.
I take metformin or an acid blocker – is a tablet enough? Both medicines act at points that the passive route bypasses, which is why high-dose products can work here in principle. Whether that is sufficient in an individual case is shown only by checking the values, and that belongs in medical hands – particularly because the MHRA explicitly recommends monitoring in patients at risk who are taking metformin.
Then why do injections still exist at all? Because high oral doses presuppose daily reliability, and because a pronounced, already symptomatic deficiency requires a lot of vitamin quickly. That decision is a medical one; a food supplement does not replace it.
Is B12 absorbed less well with age? Protein-bound B12 from foods, yes – especially where atrophic gastritis is present, which is reported at 7 to 32 % in older adults. Crystalline B12 from supplements or fortified foods is not affected in the same way; the percentage absorbed does not fall noticeably with age.
